Connie Johnson Breast Cancer Research
The Connie Johnson Breast Cancer Research Group is a translational research laboratory that was established in 2015. We perform clinically focused laboratory research in partnership with patients who generously donate their tissues as critical building blocks for our experiments. These include the establishment of patient-derived breast tumour xenografts in mice, and the comparison of normal and breast cancer tissue in patients.
We evaluate novel therapies in these preclinical breast cancer models, allowing us to understand the mechanisms of action and resistance, and to develop the preclinical rationale to move these treatments into clinical trials in patients. Another major focus of our group is hormone receptors (such as the estrogen and androgen receptors) in breast cancers, and identifying ways to sensitise these cancer cells to endocrine therapies.
Our research is funded through the National Breast Cancer Foundation, Cancer Australia, Australia & New Zealand Breast Cancer Trialist Group, St Vincent's Clinic Foundation and the Love Your Sister foundation.
In the News
Inaugural grant funds simultaneous breast and prostate cancer research - Sep 19, 2017
Vale Connie Johnson OAM - Sep 11, 2017
Love Your Sister's Big Heart Project raises over $2 million for cancer research - May 11, 2017
Garvan breast cancer researcher awarded 10-year Endowed Chair - Mar 23, 2017
Translational breast cancer research – translated to the public - Feb 14, 2017
The Rebecca Wilson Fellowship in Breast Cancer Research launches - Feb 08, 2017
NHMRC: grants success for Garvan researchers - Dec 05, 2016
Inaugural Rebecca Wilson Fellowship in Breast Cancer Research recipient announced - Nov 01, 2016
Garvan welcomes inaugural Connie Johnson clinical laboratory head - Aug 19, 2015
Garvan Institute announces recipient of the Connie Johnson Award for Breast Cancer Research - May 27, 2015